The FTC Workshops 'Gender Medicine' As Potential Medical Fraud This Week

The Distance will report from the discussion in Washington, DC

As I mentioned at the end of my piece for Genspect last week, I will be in Washington, DC this week to report for The Distance from a Federal Trade Commission workshop on the inherent frauds of ‘gender medicine’.

From an historian’s perspective, ‘gender medicine’ is an example of patent medical fraud. Its consequences in children are more profound than adults, yet the experimental ‘transition’ of minors was predicated on improving the dismal results in adults.

It was all predicated on a lie that human sex can be changed to fit a ‘spectrum’ of political identities. Sooner or later, the practitioners were bound to collide with civil and even criminal consumer protection law. History appears to be rhyming. I intend to be a witness and chronicler of this momentous occasion.

Understanding ‘Gender Affirmation’ as a Patent Medicine Show

This is of course an expensive trip. If you are a free subscriber, please consider becoming a paid subscriber. You will have access to my full podcast with Stella O’Malley, the founder of Genspect, tomorrow, plus early …